SCHEMBL12247474

SCHEMBL12247474

CC(C)(C)S(=O)(=O)CCCOCCOCCOCCCS(=O)(=O)C(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12247469 0.91 KDM4E (0.33) TSHR
SCHEMBL12300025 0.90 CYP3A4 (0.31) CYP3A4TSHR
SCHEMBL12299416 0.81 FAAH (0.33)
SCHEMBL779447 0.79 CA2 (0.38)
SCHEMBL12247470 0.76 CA2 (0.41)
SCHEMBL5555393 0.76
SCHEMBL4697072 0.73 LMNA (0.39) TSHR
SCHEMBL18876671 0.73
SCHEMBL2304274 0.72 CA2 (0.43) TSHR
SCHEMBL3121124 0.72 CA2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230419-A1 IAP BINDING COMPOUNDS NUEVOLUTION A/S (DK) 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230419-A1 IAP BINDING COMPOUNDS BIRC5, BIRC7, BIRC3 CYP3A4 3839/4885TSHR 4815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.